Medical News

RSS

Researchers develop new hand-held instrument for glaucoma screening

A new hand-held instrument involving a system of micro-force sensors, specially designed microchips, and math-based programmed procedures has been designed by researchers at the UA College of Engineering. The easy-to-use probe gently rubs the eyelid and can be used at home, threatening to replace painful eye drops and the need for a sterilized sensor.

5 Jan 2011

Seattle Times looks at response to Haitian cholera outbreak on the ground

Though Haiti's cholera "epidemic continues to spread, infecting more than 125,000 people and killing more than 3,200," it seems to have "stabilized in" the town of Mirebalais, which is close to the "U.N. camp of Nepalese peacekeepers who are under investigation as a possible source" of the outbreak, the Seattle Times reports in a story outlining how aid groups and health workers are dealing with the situation.

5 Jan 2011

Study suggests new experimental drug is better than standard morphine

A little-known morphinelike drug is potentially more potent, longer lasting and less likely to cause constipation than standard morphine, a study led by a Loyola University Health System anesthesiologist has found.

5 Jan 2011

Santaris Pharma, Pfizer expand RNA-targeted medicine collaboration

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, and Pfizer Inc., today announced that the companies have expanded their collaboration directed to the development and commercialization of RNA-targeted medicines using Santaris Pharma A/S Locked Nucleic Acid (LNA) Drug Platform.

5 Jan 2011

Grubb & Ellis Healthcare announces acquisition of Lawton Medical Office Building Portfolio

Grubb & Ellis Healthcare REIT II, Inc. today announced that it has acquired Lawton Medical Office Building Portfolio, a two-property medical office building portfolio on the campus of Southwestern Medical Center in Lawton, Okla., and Ennis Medical Office Building, a 30,000-square-foot medical office building in Ennis, Texas.

5 Jan 2011

Footstar to acquire CPEX Pharmaceuticals

Footstar, Inc. announced today that certain of its subsidiaries have entered into a definitive merger agreement with CPEX Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, in a transaction valued at approximately $76.6 million, plus fees and expenses relating to the transaction.

5 Jan 2011

New wound care eLearning Portal for clinicians

Derma Sciences, a medical device and pharmaceutical company focused on advanced wound care, announces the launch of a new eLearning Portal to provide clinicians with valuable educational programs to ensure they are kept abreast of the latest information and product solutions in the Company's advanced wound care line.

5 Jan 2011

Republican push to undo health law will be no easy task

Even as the GOP flexes its new political muscle, news outlets offer analysis of the difficulties involved in the long-term strategy to prevent the health law's implementation — including the difficulties involved in attempts to defund it. Meanwhile, PBS explores how this debate could trigger the return of the "death panel" issue.

5 Jan 2011

Study reviews effects of supplements on mental energy

The Life Sciences Research Organization, Inc. (LSRO) has published a review article in the December 2010 issue of Nutrition Reviews entitled Do Specific Constituents and Supplements Affect Mental Energy? Review of the Evidence.

5 Jan 2011

Kiadis Pharma, Hospira sign license agreement to develop and commercialize ATIR hematology product

Kiadis Pharma, a biopharmaceutical company based in The Netherlands, announced that it has entered into a licensing agreement with Hospira, Inc., a global specialty pharmaceutical company, to develop and commercialize Kiadis Pharma's ATIR™.

5 Jan 2011

Vaccinex receives FDA clearance to initiate VX15/2503 Phase 1 clinical trial in advanced solid tumors

Vaccinex, Inc. announced today that it has received clearance from FDA and will initiate a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of therapeutic antibody candidate VX15/2503 in cancer patients with advanced solid tumors.

5 Jan 2011

Study: Stem cells play an unexpected role in male pattern balding

Given the amount of angst over male pattern balding, surprisingly little is known about its cause at the cellular level. In a new study, published in the Journal of Clinical Investigation, a team led by George Cotsarelis, MD, chair of the Department of Dermatology at the University of Pennsylvania School of Medicine, has found that stem cells play an unexpected role in explaining what happens in bald scalp.

5 Jan 2011

FDA approves Gore's C3 Delivery System to deploy EXCLUDER AAA Endoprosthesis

W. L. Gore & Associates (Gore) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market the GORE® C3 Delivery System to deploy the GORE® EXCLUDER® AAA Endoprosthesis as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA).

5 Jan 2011

Roundup: Calif. issues emergency medical care expenditure regs; High risk pools in Mich., Wis. face stumbling blocks

California's new insurance commissioner sought Monday to force health insurers to spend more of their revenue on medical care. In his first official act, Insurance Commissioner Dave Jones ordered emergency regulations requiring insurance companies to devote at least 80% of their income to policyholders' claims in the state's individual insurance market (Helfand, 1/4).

5 Jan 2011

Increased amounts of MMP-1 enzyme may explain preeclampsia symptoms in pregnant women

Virginia Commonwealth University School of Medicine researchers have found that a significant increase of an enzyme in the blood vessels of pregnant women with preeclampsia may explain some of the symptoms associated with the condition, including hypertension, swelling and protein in the urine.

5 Jan 2011

VENENUM Biodesign relocates to new, state-of-the-art facility in Hamilton

VENENUM Biodesign, a drug discovery company that utilizes ultra-high throughput screening (UHTS) of its compound collection to identify hits against its novel disease-based targets or its partners' targets, announced today its relocation to a brand-new, state-of-the-art facility in Hamilton, NJ in Mercer County.

5 Jan 2011

Get examined during Glaucoma Awareness Month

It happens slowly. Over time, a person's vision will get worse. Until one day, that person can no longer see. Glaucoma is the second leading cause of blindness in the United States and worldwide. Unfortunately, there is no cure. Once a person's vision is lost, it cannot be regained. That is why Dr. Bizer's VisionWorld is encouraging people to get an examination during Glaucoma Awareness Month.

5 Jan 2011

Governors take hard look at Medicaid dollars, programs

Amidst continuing state budget pressures, N.Y. Gov. Andrew Cuomo plans to reduce Medicaid spending by a hefty sum; Missouri's new governor pledges to reverse his predecessor's cuts; and in Kansas, program reforms are part of Gov. Brownback's agenda.

5 Jan 2011

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

5 Jan 2011

Diet low in micronutrients can contribute to metabolic syndrome

Results of an epidemiological study conducted by researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and the Corporacion Ecuatoriana de Biotecnologia showed that the metabolic syndrome, a condition that increases a person's risk of developing cardiovascular disease and type 2 diabetes, was prevalent in a low-income urban community in Ecuador and that a poor diet low in micronutrients appeared to contribute.

5 Jan 2011